The emphasis placed on tackling and preventing lifestyle-related diseases in the NHS Five Year Forward View underlines the importance of the Public Health Responsibility Deal and the part it plays in supporting people to make healthier choices and tackle the behaviours which lead to chronic health conditions. Over 700 community, voluntary, public sector (National Health Service as well as national and local Government), public health and commercial organisations have signed up to play their part in improving public health.<\/p>
<\/p>
<\/p>
<\/p>
The Deal is already focussed on tackling many of the key causes of lifestyle-related ill health outlined in the NHS Five Year Forward View, including obesity, smoking and harmful drinking. The Deal\u2019s pledges tackle a wide range of issues, including: healthier diets (e.g. reformulation for reduced salt levels, elimination of trans-fats and calorie reduction); fostering a culture of responsible drinking (e.g. lower alcohol by volume products, alcohol labelling, increasing awareness of alcohol units); increasing physical activity levels (e.g. physical activity in the workplace and active travel) and improving the health of their staff (e.g. accreditation of occupational health services, supporting employees with mental health conditions in the workplace, smoking cessation and healthier staff restaurants). The Deal will continue to play an important part in delivering these ambitions.<\/p>
<\/p>
<\/strong><\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:09:23.2443948Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Public Health: Business"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, with reference to the emphasis placed on tackling and preventing lifestyle-related diseases in the NHS Five Year Forward View, published in October 2014, whether he has any plans to review and reform the voluntary responsibility deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "211871"}
, {"_about" : "http://data.parliament.uk/resources/100881", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100881/answer", "answerText" : {"_value" : " The National Health Service has two \u2018Trexler\u2019 beds on stand-by 24 hours a day at the Royal Free Hospital in London, available for use within six hours maximum to allow staff to be mobilised. If needed further beds at the Royal Free Hospital, Newcastle Royal Victoria Infirmary, Royal Liverpool and Broadgreen University Hospital and Sheffield Teaching Hospital would be made available, totalling 12 beds.<\/p> <\/p> <\/p> <\/p> The Department believes this will be sufficient even in the event of an increase in the numbers of cases of Ebola in this country. If there is a significant upscale in numbers further beds could be made available. This would amount to at least 26 beds referenced in the Secretary of State for Health\u2019s statement on 13 October, Official Report, <\/em>Column 30.<\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:30:23.639361Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ebola"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, pursuant to his contribution of 13 October 2014, Official Report, column 30, on bed capacity for dealing with potential Ebola patients, how many additional beds will be made available; and at which hospitals they will be made available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"}
}
, "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"}
, "tablingMemberPrinted" : [{"_value" : "Luciana Berger"}
], "uin" : "211872"}
, {"_about" : "http://data.parliament.uk/resources/100882", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100882/answer", "answerText" : {"_value" : " National Institute for Health and Care Excellence\u2019s independent advisory committee recommends new indicators or changes to existing indicators. NHS Employers, on behalf of NHS England, then negotiate with the General Practitioners Committee of the British Medical Association on which of the published indicators should be applied nationally and what the financial value and payment thresholds for those indicators should be.<\/p> <\/p> <\/p> <\/p> There are currently four indicators within the Quality and Outcomes Framework (QOF) that relate to cervical screening. These have had a positive impact upon increasing the participation in the screening programme in the past years. In April this year, one indicator on cervical screening: The contractor ensures there is a system for informing all women of the results of cervical screening tests<\/em> was retired, as part of efforts to reduce QOF by more than a third to free up space for GPs to provide more personalised care. Indicators were retired where they were duplicating other existing incentives, were of low clinical value, were unnecessarily prescriptive or were already embedded in clinical practice. The removal of the indicators will reduce bureaucracy, unnecessary patient testing and unnecessary frequency of patient recall and recording.<\/p> <\/p> <\/p> <\/p> There are two indicators that are relevant for all cancers. Indicators on Breast and Bowel Cancer are not currently within the QOF; however Public Health England will continue to explore with NICE whether these conditions should be included.<\/p> <\/p> <\/p> For 2015-16, there will not be any alterations to the cervical screening or cancer indicators, nor any new indicators for cancer, including breast and bowel cancer.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "211903"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:20:41.6334978Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cervical Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what his policy is on the retention of cervical cancer indicators in the Quality and Outcomes Framework.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1390", "label" : {"_value" : "Biography information for Mr John Baron"}
}
, "tablingMemberConstituency" : {"_value" : "Basildon and Billericay"}
, "tablingMemberPrinted" : [{"_value" : "Mr John Baron"}
], "uin" : "211899"}
, {"_about" : "http://data.parliament.uk/resources/100883", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100883/answer", "answerText" : {"_value" : " Since September 2012 I have visited:<\/p> <\/p> <\/p> <\/p> 23 December 2013, St Thomas\u2019s hospital<\/p> <\/p> <\/p> <\/p> 6 March 2014, Kings College hospital<\/p> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:28:08.7515376Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hospitals: Greater London"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many times the Parliamentary Under-Secretary of State for Public Health has visited (a) Chelsea and Westminster Hospital, (b) Royal Brompton Hospital, (c) King's College Hospital and (d) St Thomas's Hospital in her ministerial capacity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1503", "label" : {"_value" : "Biography information for Mr Jamie Reed"}
}
, "tablingMemberConstituency" : {"_value" : "Copeland"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jamie Reed"}
], "uin" : "211900"}
, {"_about" : "http://data.parliament.uk/resources/100889", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100889/answer", "answerText" : {"_value" : " National Institute for Health and Care Excellence\u2019s independent advisory committee recommends new indicators or changes to existing indicators. NHS Employers, on behalf of NHS England, then negotiate with the General Practitioners Committee of the British Medical Association on which of the published indicators should be applied nationally and what the financial value and payment thresholds for those indicators should be.<\/p> <\/p> <\/p> <\/p> There are currently four indicators within the Quality and Outcomes Framework (QOF) that relate to cervical screening. These have had a positive impact upon increasing the participation in the screening programme in the past years. In April this year, one indicator on cervical screening: The contractor ensures there is a system for informing all women of the results of cervical screening tests<\/em> was retired, as part of efforts to reduce QOF by more than a third to free up space for GPs to provide more personalised care. Indicators were retired where they were duplicating other existing incentives, were of low clinical value, were unnecessarily prescriptive or were already embedded in clinical practice. The removal of the indicators will reduce bureaucracy, unnecessary patient testing and unnecessary frequency of patient recall and recording.<\/p> <\/p> <\/p> <\/p> There are two indicators that are relevant for all cancers. Indicators on Breast and Bowel Cancer are not currently within the QOF; however Public Health England will continue to explore with NICE whether these conditions should be included.<\/p> <\/p> <\/p> For 2015-16, there will not be any alterations to the cervical screening or cancer indicators, nor any new indicators for cancer, including breast and bowel cancer.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "211899"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:20:41.4400608Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what his policy is on the inclusion of (a) breast and (b) bowel cancer indicators in the Quality and Outcomes Framework.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1390", "label" : {"_value" : "Biography information for Mr John Baron"}
}
, "tablingMemberConstituency" : {"_value" : "Basildon and Billericay"}
, "tablingMemberPrinted" : [{"_value" : "Mr John Baron"}
], "uin" : "211903"}
, {"_about" : "http://data.parliament.uk/resources/100891", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100891/answer", "answerText" : {"_value" : " The National Institute for Health and Care Excellence (NICE) has published cancer service guidance which outlines how healthcare services for people with skin tumours, including melanoma, should be organised. In May 2010 NICE issued a partial update to the guidance, including new recommendations on the management of low-risk basal cell carcinomas in the community.<\/p> <\/p> <\/p> <\/p> NICE is currently developing a clinical guideline on the assessment and management of melanoma, which is currently planned for publication in July 2015.<\/p> <\/p> Further details of NICE\u2019s guidance on skin cancer are available at:<\/p> <\/p> <\/p> <\/p> Age Group<\/p><\/td> Uptake Rate (%)<\/p><\/td><\/tr> People aged 65 years or older<\/p><\/td> 44.6<\/p><\/td><\/tr> People aged six months to under 65 years in risk groups<\/p><\/td> 25.2<\/p><\/td><\/tr> Pregnant women<\/p><\/td> 22.4<\/p><\/td><\/tr> Children aged two years old<\/p><\/td> 8.1<\/p><\/td><\/tr> Children aged three years old<\/p><\/td> 8.8<\/p><\/td><\/tr> Children aged four years old<\/p><\/td> 6.5<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> Vaccine uptake rates for those aged 65 and over, those under 65 with a clinical condition, and pregnant women are slightly higher than at the same point in the last two years. Uptake for two and three year olds is lower than at this point a year ago. For the new cohort of four year olds, vaccination levels are similar to those for two and three year olds.<\/p> <\/p> <\/p> <\/p> It is not possible to make an assessment of the effectiveness of the 2014-15 influenza immunisation programme at this very early stage before the influenza virus is circulating. The planned programme of campaign communication is ongoing.<\/p> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-30T16:57:25.8382413Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Influenza: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the (a) uptake and (b) effectiveness of the influenza immunisation vaccine campaign.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1388", "label" : {"_value" : "Biography information for Lord Dodds of Duncairn"}
}
, "tablingMemberConstituency" : {"_value" : "Belfast North"}
, "tablingMemberPrinted" : [{"_value" : "Mr Nigel Dodds"}
], "uin" : "211669"}
, {"_about" : "http://data.parliament.uk/resources/100707", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100707/answer", "answerText" : {"_value" : " Public Health England (PHE) strongly encourages women to take a folic acid supplement from before they are pregnant to the 12th week of pregnancy, to reduce the risk of having a baby with a neural tube defect. This advice is included in public health messages around pregnancy and planning a pregnancy.<\/p> <\/p> <\/p> <\/p> National Institute for Health and Care Excellence guidance states that advice on folic acid supplementation should be provided as part of antenatal care at first contact with a healthcare professional. Advice on folic acid supplementation for women who are pregnant or planning a pregnancy, is disseminated through a variety of sources including the NHS Choices website, the NHS Information Service for Parents, the charity \u2018Tommy\u2019s\u2019, and Start4Life - PHE\u2019s campaign to give babies the best start in life and reduce the risk of poor health in the future.<\/p> <\/p> <\/p> <\/p> PHE has recently established a media partnership to communicate the key healthy behaviour messages prior to conception in more mainstream women\u2019s magazine media.<\/p> <\/p> <\/strong><\/p> <\/p> In addition, the Department has commissioned the Behavioural Insights Team to look at innovative approaches to raising awareness of the need to take folic acid supplements during pregnancy. This programme of work is scheduled for completion by the end of January 2015.<\/p> <\/p> <\/strong><\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-30", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-30T16:59:32.35103Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Neural Tube Defects: Folic Acid"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to raise awareness of the use of folic acid prior to conception as a preventative measure for neural tube defects.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1388", "label" : {"_value" : "Biography information for Lord Dodds of Duncairn"}
}
, "tablingMemberConstituency" : {"_value" : "Belfast North"}
, "tablingMemberPrinted" : [{"_value" : "Mr Nigel Dodds"}
], "uin" : "211670"}
, {"_about" : "http://data.parliament.uk/resources/100708", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100708/answer", "answerText" : {"_value" : " The Public Health Outcomes Framework launched in 2012 includes an indicator on preventable sight loss which tracks sight loss due to the three main causes: age related macular degeneration, diabetic retinopathy and glaucoma. Data has been published for 2010-11, 2011-12 and 2012-13 and the number of people aged 12 years and above who lost their eye sight from diabetes is shown in the following table.<\/p> <\/p> <\/p> <\/p> A sight loss indicator per 100,000 people for England for each of the three years is also included. The source of the data is Public Health England\u2019s outcomes website and the links to the data are below the table.<\/p> <\/p> <\/p> <\/p> Indicator<\/p><\/td> Year<\/p><\/td> Indicator value per 100,000 population<\/p><\/td> Number of people who lost their eye sight from diabetes<\/p><\/td><\/tr> 4.12iii - Preventable sight loss - diabetic eye disease<\/p><\/td> 2010-11<\/p><\/td> 3.6<\/p><\/td> 1,611<\/p><\/td><\/tr> 4.12iii - Preventable sight loss - diabetic eye disease<\/p><\/td> 2011-12<\/p><\/td> 3.8<\/p><\/td> 1,755<\/p><\/td><\/tr> 4.12iii - Preventable sight loss - diabetic eye disease<\/p><\/td> 2012-13<\/p><\/td> 3.5<\/p><\/td> 1,592<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> Source:<\/em><\/p> <\/p>